Skip to main content
Figure 4 | Critical Care

Figure 4

From: Risk assessment in sepsis: a new prognostication rule by APACHE II score and serum soluble urokinase plasminogen activator receptor

Figure 4

Kaplan-Meier estimates of survival of patients enrolled in the study cohort stratified into four strata of severity by APACHE II score and serum suPAR. Every curve differed significantly from the others. Log-rank tests of comparisons are stratum (i) versus stratum (ii) 43.93 (P < 0.0001), stratum (ii) versus stratum (iii) 33.72 (P < 0.0001), and stratum (iii) versus stratum (iv) 14.43 (P < 0.0001). APACHE II, Acute Physiology and Chronic Health Evaluation II; suPAR, soluble urokinase plasminogen activator receptor.

Back to article page

Critical Care

ISSN: 1364-8535